Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Hansen

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Toxicology and Applied Pharmacology|February 1, 1991
Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: comparisons of pulmonary responses to carbonyl iron and silicaD B Warheit, M C Carakostas, M A Hartsky, et al.
Acta Cardiologica|January 1, 1990
Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmiasH Nielsen, C Sørum, V Rasmussen, et al.
Ugeskrift for Laeger|March 24, 1986
[Hyperlipidemia. Diagnostic and therapeutic guidelines]O Faergeman, J F Hansen, T Hilden, et al.
Cardiology|May 1, 1996
Prognostic value of echocardiography in 190 patients with chronic congestive heart failure. A comparison with New York Heart Association functional classes and radionuclide ventriculographyB K Madsen, R Videbaek, H Stokholm, et al.
Scandinavian Cardiovascular Journal : SCJ|December 23, 1998
Improvement in long-term prognosis of elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapyJ K Madsen, F Pedersen, H Nielsen, et al.
BMJ (Clinical Research Ed.)|May 7, 1994
Ten year mortality in patients with suspected acute myocardial infarctionJ Launbjerg, P Fruergaard, J K Madsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Circadian variation in the pharmacokinetics of verapamilC M Jespersen, M Frederiksen, J F Hansen, et al.
Cardiology|January 1, 1994
Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction TrialJ Launbjerg, P Fruergaard, J K Madsen, et al.
BMJ (Clinical Research Ed.)|January 21, 2000
Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic testsO W Nielsen, J F Hansen, J Hilden, et al.
Ugeskrift for Laeger|July 3, 1995
[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge]J Launbjerg, P Fruergaard, J K Madsen, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Toxicology and Applied Pharmacology|February 1, 1991
Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: comparisons of pulmonary responses to carbonyl iron and silicaD B Warheit, M C Carakostas, M A Hartsky, et al.
Acta Cardiologica|January 1, 1990
Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmiasH Nielsen, C Sørum, V Rasmussen, et al.
Ugeskrift for Laeger|March 24, 1986
[Hyperlipidemia. Diagnostic and therapeutic guidelines]O Faergeman, J F Hansen, T Hilden, et al.
Cardiology|May 1, 1996
Prognostic value of echocardiography in 190 patients with chronic congestive heart failure. A comparison with New York Heart Association functional classes and radionuclide ventriculographyB K Madsen, R Videbaek, H Stokholm, et al.
Scandinavian Cardiovascular Journal : SCJ|December 23, 1998
Improvement in long-term prognosis of elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapyJ K Madsen, F Pedersen, H Nielsen, et al.
BMJ (Clinical Research Ed.)|May 7, 1994
Ten year mortality in patients with suspected acute myocardial infarctionJ Launbjerg, P Fruergaard, J K Madsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Circadian variation in the pharmacokinetics of verapamilC M Jespersen, M Frederiksen, J F Hansen, et al.
Cardiology|January 1, 1994
Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction TrialJ Launbjerg, P Fruergaard, J K Madsen, et al.
BMJ (Clinical Research Ed.)|January 21, 2000
Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic testsO W Nielsen, J F Hansen, J Hilden, et al.
Ugeskrift for Laeger|July 3, 1995
[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge]J Launbjerg, P Fruergaard, J K Madsen, et al.
Pageof 17